KORU offers support for clinical trials, market launch, or product reformulations – they can aid in the organization and implementation of your high-capacity subcutaneous (SC) medication delivery. KORU prioritizes the needs of patients and is dedicated to providing exceptional service to customers, healthcare providers, and partners relying on their medical devices. They specialize in manufacturing subcutaneous infusion products designed to administer crucial immunoglobulin treatments to individuals battling long-term conditions such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). Their focus lies in delivering infusion solutions, particularly for home and specialized care, and they place great emphasis on offering effective problem-solving services with a strong focus on enhancing the patient's overall treatment experience.